- Previous close
0.0370 - Open
0.0350 - Bid 0.0330 x --
- Ask 0.0390 x --
- Day's range
0.0320 - 0.0410 - 52-week range
0.0290 - 0.0540 - Volume
500,300 - Avg. Volume
78,284 - Market cap (intra-day)
10.841M - Beta (5Y monthly) 2.10
- PE ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings date 14 Nov 2024
- Forward dividend & yield --
- Ex-dividend date 3 Oct 2008
- 1y target est
--
Accrelist Ltd., an investment holding company, provides aesthetic medical services. It operates through three segments: Financial Technology, Mechanical Business Unit (MBU), and Aesthetic Medical Services (AMS). The Financial Technology segment provides financial services, such as crowdfunding to enable users to raise funds for their projects and electronic wallet services granting users an alternate mode of payment. The MBU segment offers mould design and fabrication services for consumer electronics, household appliances, automotive and computer peripherals, as well as precision plastic injection moulding services for their customers' finished products. The AMS segment offers services related to aesthetic enhancements. The company also provides petroleum, mining, and prospecting services; trades in iron ore and coal; and retails pharmaceutical and medical goods. It has operations in Singapore, the United States, Malaysia, the People's Republic of China, India, Indonesia, Vietnam, and internationally. The company was formerly known as WE Holdings Ltd. and changed its name to Accrelist Ltd. in November 2016. Accrelist Ltd. was incorporated in 1986 and is headquartered in Singapore.
www.accrelist.com.sg--
Full-time employees
31 March
Fiscal year ends
Healthcare
Sector
Medical Care Facilities
Industry
Related news
View more
Performance overview: QZG.SI
Trailing total returns as of 22/11/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: QZG.SI
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: QZG.SI
View moreValuation measures
Market cap
11.51M
Enterprise value
5.17M
Trailing P/E
3.68
Forward P/E
--
PEG ratio (5-yr expected)
--
Price/sales (ttm)
0.67
Price/book (mrq)
0.89
Enterprise value/revenue
0.31
Enterprise value/EBITDA
0.74
Financial highlights
Profitability and income statement
Profit margin
-13.94%
Return on assets (ttm)
-8.12%
Return on equity (ttm)
-26.36%
Revenue (ttm)
16.67M
Net income avi to common (ttm)
-6.62M
Diluted EPS (ttm)
-0.0100
Balance sheet and cash flow
Total cash (mrq)
10.03M
Total debt/equity (mrq)
16.17%
Levered free cash flow (ttm)
943.62k